Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 1
2010 4
2011 14
2012 18
2013 7
2014 21
2015 28
2016 30
2017 30
2018 42
2019 54
2020 41
2021 47
2022 40
2023 36
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Alirocumab on Carotid Inflammation by [18F]FDG PET in Patients With Acute Myocardial Infarction.
Bang LE, Jensen JK, Räber L, Koskinas KC, Bär S, Losdat S, Matter CM, Lonborg J, Radu Juul Jensen MD, Kjaer A, Engstrøm T, Ripa RS. Bang LE, et al. Among authors: raber l. JACC Cardiovasc Imaging. 2024 Apr 10:S1936-878X(24)00131-1. doi: 10.1016/j.jcmg.2024.04.001. Online ahead of print. JACC Cardiovasc Imaging. 2024. PMID: 38678449 No abstract available.
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study.
Bruno F, Wenzl FA, De Filippo O, Kraler S, Giacobbe F, Roffi M, Muller O, Räber L, Templin C, Maria De Ferrari G, D'Ascenzo F, Lüscher TF. Bruno F, et al. Among authors: raber l. Eur Heart J Cardiovasc Pharmacother. 2024 Apr 11:pvae024. doi: 10.1093/ehjcvp/pvae024. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38604747
Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
Rexhaj E, Bär S, Soria R, Ueki Y, Häner JD, Otsuka T, Kavaliauskaite R, Siontis GC, Stortecky S, Shibutani H, Spirk D, Engstrøm T, Lang I, Morf L, Ambühl M, Windecker S, Losdat S, Koskinas KC, Räber L; PACMAN-AMI Investigators. Rexhaj E, et al. Among authors: raber l. Atherosclerosis. 2024 May;392:117504. doi: 10.1016/j.atherosclerosis.2024.117504. Epub 2024 Mar 6. Atherosclerosis. 2024. PMID: 38513436 Free article. Clinical Trial.
Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes.
Eppinger S, Piayda K, Galea R, Sandri M, Maarse M, Güner A, Karabay CY, Pershad A, Ding WY, Aminian A, Akin I, Davtyan KV, Chugunov IA, Marijon E, Rosseel L, Schmidt TR, Amabile N, Korsholm K, Lund J, Guerios E, Amat-Santos IJ, Boccuzzi G, Ellis CR, Sabbag A, Ebelt H, Clapp B, Assa HV, Levi A, Ledwoch J, Lehmann S, Lee OH, Mark G, Schell W, Della Rocca DG, Natale A, de Backer O, Kefer J, Esteban PP, Abelson M, Ram P, Moceri P, Galache Osuna JG, Alvarez XM, Cruz-Gonzalez I, de Potter T, Ghassan M, Osadchiy A, Chen W, Goyal SK, Giannini F, Rivero-Ayerza M, Afzal S, Jung C, Skurk C, Langel M, Spence M, Merkulov E, Lempereur M, Shin SY, Mesnier J, McKinney HL, Schuler BT, Armero S, Gheorghe L, Ancona MBM, Santos L, Mansourati J, Nombela-Franco L, Nappi F, Kühne M, Gaspardone A, van der Pals J, Montorfano M, Fernández-Armenta J, Harvey JE, Rodés-Cabau J, Klein N, Sabir SA, Kim JS, Cook S, Kornowski R, Saraste A, Nielsen-Kudsk JE, Gupta D, Boersma L, Räber L, Sievert K, Sievert H, Bertog S. Eppinger S, et al. Among authors: raber l. Cardiovasc Revasc Med. 2024 Feb 28:S1553-8389(24)00067-8. doi: 10.1016/j.carrev.2024.02.014. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38448258
391 results